|
Mar. 09, 2026 |
|
|
July. 16, 2026 |
|
|
jRCT1031250782 |
A prospective randomized controlled trial of remimazolam versus propofol on cerebral oxygenation during laminectomy in prone position under general anesthesia (PRO-REM Trial) |
|
A prospective randomized controlled trial of remimazolam versus propofol on cerebral oxygenation during laminectomy in prone position under general anesthesia (PRO-REM Trial) |
Ueda Kenichi |
||
Kameda Medical Center |
||
929, Higashi-cho, Kamogawa City, Chiba |
||
+81-4-7092-2211 |
||
ueda.kenichi@kameda.jp |
||
Lazaro Betina |
||
Kameda Medical Center |
||
929, Higashi-cho, Kamogawa City, Chiba |
||
+81-4-7092-2211 |
||
betina.lazaro@kameda.jp |
Recruiting |
Mar. 06, 2026 |
||
| Mar. 06, 2026 | ||
| 60 | ||
Interventional |
||
randomized controlled trial |
||
single blind |
||
no treatment control/standard of care control |
||
parallel assignment |
||
treatment purpose |
||
1. Elderly patients over 65 years of age |
||
1. Uncontrolled cardiovascular disease (e.g., EF<30% heart failure, Af, other severe arrhythmias) |
||
| 65age old over | ||
| No limit | ||
Both |
||
Patients with spinal disease at the thoracic and/or lumbar level requiring laminectomy, discectomy, |
||
Patients undergoing spine surgery in the prone position will be randomized to remimazolam (Group R) or propofol (Group P), with continuous cerebral oximetry monitoring and hemodynamics-guided vasopressor administration. |
||
spinal stenosis |
||
Laminectomy |
||
D013130 |
||
D007796 |
||
Between-group difference in time-weighted average delta rScO2 in the prone position relative to pre-induction supine baseline. |
||
1. Incidence of cerebral oxygen saturation decrease events |
||
| Kameda Medical Center Clinical Research Review Committee | |
| 929 Higashi-cho, Kamogawa City, Chiba, Chiba | |
+81-4-7092-2211 |
|
| clinical_research@kameda.jp | |
| Approval | |
Feb. 05, 2026 |
none |